Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.

Highest usefulness score first. Studies without a score come last.

  1. A computer-based cognitive training in Mild Cognitive Impairment in Parkinson's Disease

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. NeuroRehabilitation 2019-01-01 Prevention trials

    Patients trained with CoRe showed a better evolution of cognitive decline, while untreated patients tended to get worse over time.

  2. A Mediterranean diet supplemented with dairy foods improves mood and processing speed in an Australian sample: results from the MedDairy randomized controlled trial

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Nutritional neuroscience 2018-11-08 Prevention trials

    Our study provides evidence that a Mediterranean diet supplemented with dairy foods may benefit cognitive function and psychological well-being in an ageing population at risk of dementia.

  3. Association of Clinical Outcomes With Surgical Repair of Hip Fracture vs Nonsurgical Management in Nursing Home Residents With Advanced Dementia

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. JAMA internal medicine 2018-06-01 End-of-life care

    Surgical repair of a hip fracture was associated with lower mortality among NH residents with advanced dementia and should be considered together with the residents' goals of care in management decisions.

  4. Current policy emphasises the importance of 'living well' with dementia, but there has been no comprehensive synthesis of the factors related to quality of life (QoL), subjective well-being or life satisfaction in people with dementia.

    Why it matters

    This review of many studies found that factors such as relationships, social engagement, and functional ability were linked to better quality of life, while poorer physical and mental health and poorer carer well-being were linked to worse quality of life. Most of these links were small, and the authors note that longitudinal evidence about what predicts quality of life was limited.

  5. Anticholinergic drugs and risk of dementia: case-control study

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. BMJ (Clinical research ed.) 2018-04-25 Getting a diagnosis

    A robust association between some classes of anticholinergic drugs and future dementia incidence was observed.

    Why it matters

    Longer and heavier use of certain anticholinergic drugs, especially antidepressants, urological, and antiparkinson drugs, was linked to a modestly higher risk of developing dementia. This was an observational case-control study, so it cannot prove that these drugs cause dementia.

  6. Association of Age-Related Hearing Loss With Cognitive Function, Cognitive Impairment, and Dementia: A Systematic Review and Meta-analysis

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. JAMA otolaryngology-- head & neck surgery 2018-02-01 Prevention and risk

    Forty studies from 12 countries met our inclusion criteria.

    Why it matters

    This meta-analysis found that age-related hearing loss was associated with a higher risk of cognitive impairment and dementia, but not with Alzheimer disease specifically. It suggests hearing loss may be a marker or risk factor for dementia, but does not show that treating hearing loss prevents dementia.

  7. The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Alzheimer's & dementia (Amsterdam, Netherlands) 2017-12-08 Caregiving

    The Wisconsin Registry for Alzheimer's Prevention is a longitudinal observational cohort study enriched with persons with a parental history (PH) of probable Alzheimer's disease (AD) dementia.

    Why it matters

    This review summarises a Wisconsin study that has followed 1,561 adults, enrolled at an average age of 54 and many with a parent who had Alzheimer's, for about 9 years. People with a parental history were more than twice as likely to carry the APOE ε4 gene variant (46% vs 22%), but in this group it was raised amyloid or tau levels, not family history or APOE, that went along with cognitive decline. Healthier lifestyle factors were linked to better thinking and less Alzheimer's-related brain change, but as an observational study it cannot show that those habits cause the difference.

  8. Marriage and risk of dementia: systematic review and meta-analysis of observational studies

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Journal of neurology, neurosurgery, and psychiatry 2017-11-28 Prevention and risk

    Being married is associated with reduced risk of dementia than widowed and lifelong single people, who are also underdiagnosed in routine clinical practice.

    Why it matters

    Pooling 15 observational studies with 812,047 people, this review found that lifelong single people (relative risk 1.42) and widowed people (1.20) had a higher dementia risk than married people; divorced people showed no difference. Lower education partly explained the widowhood link and poorer physical health the single-person link, and unmarried people also appeared to be underdiagnosed in routine care. The authors suggest prevention for unmarried people focus on education and physical health — an association, not proof that marriage itself protects.

  9. Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. The journals of gerontology. Series A, Biological sciences and medical sciences 2017-10-01 Disparities

    Recruitment ended in December 2014 with 16,703 Australian and 2,411 U.S. participants, a median age of 74 (range 65-98) years and 56% women.

    Why it matters

    This paper reports the baseline characteristics of people enrolled in a trial testing whether daily low-dose aspirin extends disability-free and dementia-free life in healthy older adults. It does not yet show whether aspirin prevents dementia; that will only be known once the trial's results are reported.

  10. Predictors of emergency department attendance by people with dementia in their last year of life: Retrospective cohort study using linked clinical and administrative data

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2017-08-22 End-of-life care

    ED attendance in the last year of life for people with dementia is common and is increasing.

  11. The impact of individual Cognitive Stimulation Therapy (iCST) on cognition, quality of life, caregiver health, and family relationships in dementia: A randomised controlled trial

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. PLoS medicine 2017-03-28 Cognitive tests and assessment

    Cognitive stimulation therapy (CST) is a well-established group psychosocial intervention for people with dementia.

    Why it matters

    This trial tested a home-based cognitive stimulation programme delivered by family caregivers to people with dementia, measuring cognition, quality of life and caregiver health. It is a psychosocial intervention study, and the text does not report whether it slowed, stopped or prevented Alzheimer's disease.

  12. Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. The Lancet 2017-02-18 Prevention and risk

    In a study of 2.2 million adults in Ontario, Canada, people who lived very close to a major road (within 50 meters) had a small but statistically significant higher risk of developing dementia than those living farther away (over 300 meters), even after accounting for other health and demographic factors.

    Why it matters

    This population-based cohort study found that living closer to major roads was associated with a slightly higher incidence of dementia, with the risk decreasing as distance from the road increased. It shows an association and does not prove that traffic exposure causes dementia or that moving away would prevent it.

  13. Long-term hormone therapy for perimenopausal and postmenopausal women

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. The Cochrane database of systematic reviews 2017-01-17 Prevention and risk

    We included 22 studies involving 43,637 women.

    Why it matters

    This review of hormone therapy in postmenopausal women focused on risks such as coronary events, blood clots, stroke, breast cancer, and gallbladder disease. It does not report effects on Alzheimer's disease treatment, cure, or prevention.

  14. A Comparison of the Prevalence of Dementia in the United States in 2000 and 2012

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. JAMA internal medicine 2017-01-01 How common it is

    The study cohorts had an average age of 75.0 years (95% CI, 74.8-75.2 years) in 2000 and 74.8 years (95% CI, 74.5-75.1 years) in 2012 (P = .24); 58.4% (95% CI, 57.3%-59.4%) of the 2000 cohort was female compared with 56.3% (95% CI, 55.5%-57.0%) of the 2012 cohort (P Conclusions and relevance The prevalence of dementia in the United States declined significantly between 2000 and 2012.

    Why it matters

    This study compared dementia prevalence in the United States in 2000 and 2012 using nationally representative survey data. It examines population trends in dementia prevalence and does not test any treatment, cure, or prevention.

  15. Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta-analyses

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2016-09-04 Brain tissue and pathology

    Dementia is a heterogeneous neurodegenerative disease, whose etiology results from a complex interplay between environmental and genetic factors.

    Why it matters

    This umbrella review of meta-analyses examined associations between nongenetic environmental factors and dementia, assessing 76 unique associations. It looks at possible risk factors and provides no treatment, cure or prevention.

  16. Montreal Cognitive Assessment for the diagnosis of Alzheimer's disease and other dementias

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. The Cochrane database of systematic reviews 2015-10-29 Cognitive tests and assessment

    Dementia is a progressive syndrome of global cognitive impairment with significant health and social care costs.

    Why it matters

    This meta-analysis examined how accurately the Montreal Cognitive Assessment detects Alzheimer's disease and other dementias at various thresholds. It is about diagnosis, not about treating, curing or preventing Alzheimer's disease.

  17. The burden of health care costs for patients with dementia in the last 5 years of life

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Annals of internal medicine 2015-10-27 Caregiving

    Health care expenditures among persons with dementia were substantially larger than those for other diseases, and many of the expenses were uncovered (uninsured).

    Why it matters

    In 1,702 US Medicare fee-for-service beneficiaries aged 70 or older who died in 2005–2010, average total costs over the last five years of life were $287,038 for people likely to have dementia, compared with $175,136 for heart disease, $173,383 for cancer and $197,286 for other causes. That total includes Medicare, Medicaid, private insurance, out-of-pocket spending and unpaid family care, and the authors say "many of the expenses were uncovered (uninsured)", which places a large burden on families. This is an observational comparison, and Medicaid, private insurance and informal care costs were estimated (imputed), not directly measured.

  18. A web-based psychoeducational program for informal caregivers of patients with Alzheimer's disease: a pilot randomized controlled trial

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Journal of medical Internet research 2015-05-12 Caregiving

    In this study, quantitative results were inconclusive owing to small sample size.

    Why it matters

    This pilot randomized controlled trial found no significant difference in self-perceived stress between the web-based program and control groups, though the experimental group improved their knowledge of the illness. The authors state the quantitative results were inconclusive because of the small sample size.

  19. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. JAMA psychiatry 2015-05-01 Getting a diagnosis

    Compared with respective matched nonusers, individuals receiving haloperidol had an increased mortality risk of 3.8% (95% CI, 1.0%-6.6%; P Conclusions and relevance The absolute effect of antipsychotics on mortality in elderly patients with dementia may be higher than previously reported and increases with dose.

    Why it matters

    In 90,786 veterans aged 65 or older with dementia, this study set out to measure how much a new prescription for an antipsychotic changes the absolute risk of death over 180 days. For haloperidol, death risk was 3.8 percentage points higher than in matched people not taking the drug (95% CI 1.0–6.6), and the authors conclude the absolute effect of antipsychotics "may be higher than previously reported and increases with dose." This is an observational association, not proof of cause, and it is a reason to discuss risks and alternatives with the prescriber, not to stop a medication without advice.

  20. A randomized trial to measure the impact of a community-based cognitive training intervention on balance and gait in cognitively intact Black older adults

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Health education & behavior : the official publication of the Society for Public Health Education 2014-10-01 Prevention trials

    They provide initial evidence that cognitive training may be an efficacious approach toward improving balance and gait in older adults known to have a history of falls.

  21. Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Neurology 2014-07-02 Cognitive tests and assessment

    Peripheral inflammatory markers are elevated in patients with dementia.

    Why it matters

    This cohort study examined whether midlife interleukin-6 and C-reactive protein predict cognitive decline. It investigates possible etiologic markers and does not test any treatment, cure or prevention for Alzheimer's disease.

  22. Computerized and virtual reality cognitive training for individuals at high risk of cognitive decline: systematic review of the literature

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2014-05-14 Prevention trials

    The aim of this study was to assess the efficacy of cognitive training, specifically computerized cognitive training (CCT) and virtual reality cognitive training (VRCT), programs for individuals living with mild cognitive impairment (MCI) or dementia and therefore at high risk of cognitive decline.

  23. Meditation's impact on default mode network and hippocampus in mild cognitive impairment: a pilot study

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Neuroscience letters 2013-10-10 Hippocampus size on brain scans

    Those with high baseline stress levels are more likely to develop mild cognitive impairment (MCI) and Alzheimer's Disease (AD).

  24. Long-term health benefits of physical activity--a systematic review of longitudinal studies

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. BMC public health 2013-09-08 How common it is

    This review revealed a paucity of long-term studies on the relationship between physical activity and the incidence of NCD.

    Why it matters

    This review of longitudinal studies found that physical activity appears to have a positive long-term influence on all the diseases examined, including Alzheimer's disease and dementia. It also notes a shortage of long-term studies on physical activity and these diseases.

  25. Sensitivity analyses suggest that these estimates are robust to the change in response.

    Why it matters

    Comparing two decades of data from three areas of England, this study found that people born later had a lower risk of prevalent dementia than those born earlier in the past century. It reports no treatment, cure, or prevention.

From across this topic

9 of the 7,967 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 9. The same 9 appear here every time.

Other topics